After stratifying the cases according to the IDH1 gene, we noticed that the impact of altering the CDKN2A gene, associated with mortality, was higher in the case of IDH-mutant astrocytomas (p = 0.002). Here, CDKN2A is linked to astrocytoma (excluding glioblastoma).